Badanie skuteczności stymulacji nerwu błędnego i sodu oksybatu u pacjentów z mózgową angiopatią amyloidową

Cerebral amyloid angiopathy is a condition where a protein called amyloid-beta builds up in the blood vessels of the brain. This can lead to problems like bleeding in the brain. The study aims to find out if certain treatments can help clear this protein from the brain's blood vessels. The treatments being tested include a method called non-invasive vagus nerve stimulation and a medication known as sodium oxybate, which is taken as an oral solution. Sodium oxybate is a type of medicine that affects the central nervous system.

The purpose of the study is to see if these treatments can help remove amyloid-beta from the brain's blood vessels in people with cerebral amyloid angiopathy. The study will compare the levels of amyloid-beta in the brain before and after treatment. Participants will receive either the nerve stimulation, the medication, or both. The study will last for several months, with checks on the amyloid-beta levels at different times to see if there is any change.